Catalent
CTLT
$54.72
Share price
2.18%
Change (1 day)
-48.65%
Change (1 year)
Categories
Catalent is an American pharmaceutical contract research and development company.
Market capitalization of Catalent (CTLT)
Market cap: $9.84 Billion
As of February 2023 Catalent has a market cap of $9.84 Billion. This makes Catalent the world's 1537th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Catalent from 2014 to 2023
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2023 | $9.84 B | 21.57% |
| 2022 | $8.10 B | -64.65% |
| 2021 | $22.91 B | 33.71% |
| 2020 | $17.14 B | 107.95% |
| 2019 | $8.24 B | 81.53% |
| 2018 | $4.54 B | -16.81% |
| 2017 | $5.45 B | 62.28% |
| 2016 | $3.36 B | 7.91% |
| 2015 | $3.11 B | -9.71% |
| 2014 | $3.45 B |
End of Day market cap according to different sources
On Feb 1st, 2023 the market cap of Catalent was reported to be:
$9.36 Billion
$9.84 Billion
$9.84 Billion
$9.84 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Supernus Pharmaceuticals
SUPN | $2.24 B | -77.17% | 🇺🇸 USA |
 Jazz Pharmaceuticals JAZZ | $9.93 B | 0.88% | 🇮🇪 Ireland |
 Aerie Pharmaceuticals AERI | $0.75 B | -92.35% | 🇺🇸 USA |
 Intercept Pharmaceuticals
ICPT | $0.77 B | -92.11% | 🇺🇸 USA |